% 143.77 17.1% 150.82 17.8% 4.9% 4.9% Non-controlling interests of the subsidiaries - 0.0% (1.24) -0.2% 0.42 0.1% 100.0% 100.0% Net profit - Equity holders of the Company 143.72 18.7% 145.01 17.2% 150.40
-20 -35% Non controlling interest 2 0 1 0 0 0 0 0 Profit (Loss) : Owners of the Parent 37 34 4 11% 37 57 -20 -35% According on the table above, the consolidated financial statements for the period ended
634.78 Total comprehensive loss for the period -20.77 -10.99 -9.78 -88.99 Non-controlling interests of the subsidiaries 0.05 0.04 0.01 25.00 Profit(Loss) attributable to equity holders of the company
-patients and Out-patients department inclined by 31.5 % and 5.9 % respectively. Causing from Gastrointestinal diseases and Dengue Fever including non-communicable diseases such as cardiovascular disease
payment of income tax of previous years. Loss attributable to non-controlling interests of the subsidiaries amounted to Baht 3 million in the current period as compared to a profit of Baht 10 million in the
Profit of associate company and subsidiary company when compared with the same period of last year. For 9M18, Company represented net profit of THB 458 million, a 82% growth from 9M17. Excluding the non
the period -81.93 -15.48 -66.45 -429.26 Other Comprehensive Income -0.48 -0.31 -0.17 -54.84 Total comprehensive loss for the period -82.41 -15.79 -66.62 -421.91 Non-controlling interests of the
and subsidiaries reported Baht 9,744 million in net profit, decreasing Baht 1,173 million or 10.75 percent over-quarter. The decrease could be attributed to non-interest income, which dropped Baht 3,187
risk spectrum ใหสะทอนความเสี่ยงจากการลงทุนในตราสาร non-investment grade / unrated และการกระจุกตัวในตราสารของผูออก (high concentration risk) ขอสังเกตของผูประกอบธุรกิจ ความเห็นของสํานักงาน 1) แยก high